respiratory failure: The significant impairment of gas exchange within the lungs resulting in hypoxia, hypercarbia, or both, to the extent that organ tissue perfusion is severely compromised. Causes include chronic obstructive pulmonary disease, asthma, emphysema, acute respiratory distress syndrome, pneumonia, pulmonary edema, pneumothorax, and congestive heart failure. Treatment requires intubation and mechanical ventilation until the time the lungs recover sufficient function. [NCIT:C26872]
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
5925 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
1083 |
6. Filter based on genotype QC (FinnGen only) |
1083 |
Control definitions (FinnGen only)
- Control conditions
- not ILD_ENDPOINTS
Extra metadata
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
ILD-related respiratory insufficiency
based on the number of shared cases.
Similar with more cases:
- Interstitial lung disease
- Interstitial lung disease endpoints
- Other interstitial pulmonary diseases
- Respiratory diseases principally affecting the interstitium, IBD co-morbidites
- Other respiratory diseases principally affecting the interstitium
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5976 | 2346 | 3557 |
| Only index persons | 4503 | 1795 | 2708 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.07 | 0.10 |
| Only index persons | 0.09 | 0.07 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 74.06 | 75.07 | 73.40 |
| Only index persons | 74.56 | 75.67 | 73.83 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1083 | 378 | 705 |
| Unadjusted period prevalence (%) | 0.25 | 0.13 | 0.31 |
| Median age at first event (years) | 71.97 | 69.95 | 73.06 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 952
- Matched controls
- 9518
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
10354.2
323.0
518
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
14300.2
323.0
598
*
J96.1
ICD-10 Finland
Chronic respiratory failure
80.6
323.0
449
104
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
+∞
292.2
265
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
32.8
279.6
379
188
UGC12
NOMESCO Finland
Flexible bronchoscopy
16.2
235.2
422
446
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
36.5
196.9
256
95
H02AB06
ATC
prednisolone; systemic
9.2
186.9
789
3292
TGC00
NOMESCO Finland
Bronchial lavation
37.3
176.0
227
79
J18.9
ICD-10 Finland
Pneumonia, unspecified
6.9
163.7
605
1921
WX725
NOMESCO Finland
Noninvasive ventilation
18.1
158.9
259
192
WX722
NOMESCO Finland
PEEP
15.5
157.8
276
244
XG410
NOMESCO Finland
Flow-volume spirometry
19.2
152.8
243
167
R06.0
ICD-10 Finland
Dyspnoea
6.4
147.1
537
1602
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
13.4
142.2
266
268
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.9
131.4
350
655
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
21.3
127.8
194
113
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.6
126.3
718
3365
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
9.7
122.6
274
380
284
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
121.5
114
*
C03CA01
ATC
furosemide; systemic
5.1
120.1
633
2659
R03AC02
ATC
salbutamol; inhalant
4.7
107.0
667
3161
356
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
104.1
98
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.2
101.4
395
1137
GD1AD
NOMESCO Finland
Thorax CT examination
11.4
97.9
195
211
XG466
NOMESCO Finland
Sleep oxymetry
14.4
94.9
167
138
R03BB04
ATC
tiotropium bromide; inhalant
5.5
86.7
298
722
I50.9
ICD-10 Finland
Heart failure, unspecified
4.4
80.4
368
1192
L04AX05
ATC
pirfenidone; oral
+∞
79.3
75
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.5
76.9
339
1050
L04AX01
ATC
azathioprine; systemic
11.8
76.3
147
145
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.5
75.5
176
246
R5140
NOMESCO Finland
Monitoring the use of the aid
5.7
74.1
239
525
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
5.3
71.5
249
596
TPH04
NOMESCO Finland
Cathetrisation of vein
3.9
71.2
376
1356
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
46.6
69.6
85
20
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
25.9
68.3
96
41
WX892
NOMESCO Finland
Monitored bed care
5.8
67.7
214
454
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
5.3
66.2
227
529
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
85.2
64.0
71
9
L04AA06
ATC
mycophenolic acid; systemic
21.6
63.2
94
48
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.2
62.0
478
2258
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.8
61.4
232
596
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.4
60.0
381
1549
J01MA14
ATC
moxifloxacin; systemic
5.1
58.5
206
488
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.1
58.1
266
820
Z94.2
ICD-10 Finland
Lung transplant status
+∞
57.9
55
*
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
35.8
56.7
73
22
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
55.8
53
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.5
55.1
331
1271
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
40.5
54.3
68
18
TPH07
NOMESCO Finland
Cathetrisation of artery
4.2
53.1
233
684
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.2
52.6
227
655
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.9
52.6
545
3018
L01XE31
ATC
[U] nintedanib; oral
+∞
52.6
50
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.7
51.8
272
931
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
23.9
49.6
71
32
A02BC02
ATC
pantoprazole; systemic
3.0
49.2
723
4893
G47.3
ICD-10 Finland
Sleep apnoea
3.3
48.5
299
1149
R03AK06
ATC
salmeterol and fluticasone; inhalant
3.7
48.4
250
838
I50.0
ICD-10 Finland
Congestive heart failure
4.2
47.2
202
573
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.7
47.2
145
289
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
13.3
46.5
83
68
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
+∞
45.2
43
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.3
44.1
111
169
R28
ICPC
Limited function/disability (R)
16.3
43.0
70
46
R02
ICPC
Shortness of breath/dyspnoea
3.6
40.1
207
682
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
5.1
40.1
137
306
GD1BT
NOMESCO Finland
Biopsy of lung with X-ray guidance
+∞
39.9
38
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.7
38.6
365
1806
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
38.5
296
1292
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
4.7
37.7
137
326
WX872
NOMESCO Finland
Intensive care
5.0
37.4
128
286
R4110
NOMESCO Finland
Physiotherapy
2.6
36.0
348
1726
J96.0
ICD-10 Finland
Acute respiratory failure
11.7
35.2
66
60
J01MA12
ATC
levofloxacin; systemic
2.7
34.2
281
1263
WX721
NOMESCO Finland
Oxygen concentrator therapy
79.2
34.1
38
5
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
79.2
34.1
38
5
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.7
33.6
122
289
I27.8
ICD-10 Finland
Other specified pulmonary heart diseases
34.6
33.4
43
13
127
Kela drug reimbursment
Transplant complication
13.6
33.3
58
45
Z01.8
ICD-10 Finland
Other specified special examinations
2.7
33.0
272
1221
J43.9
ICD-10 Finland
Emphysema, unspecified
9.5
32.9
69
78
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.7
32.8
264
1166
M05BA04
ATC
alendronic acid; oral
3.7
32.3
153
464
C07AB07
ATC
bisoprolol; oral
2.3
31.9
598
4060
C03DA01
ATC
spironolactone; oral
3.1
31.8
197
732
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
60.4
30.3
35
6
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.3
30.3
377
2091
J45.9
ICD-10 Finland
Asthma, unspecified
2.8
29.9
227
960
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
19.6
29.8
45
24
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
7.8
29.7
70
96
L04AD01
ATC
ciclosporin; systemic
12.1
29.4
54
47
R99
ICPC
Respiratory disease other
9.9
29.0
59
63
XX4BW
NOMESCO Finland
NA
82.8
28.9
32
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
28.6
198
787
WX704
NOMESCO Finland
Intubation
4.0
28.3
120
329
N02AX02
ATC
tramadol; systemic, rectal
2.2
28.2
474
2989
J01AA02
ATC
doxycycline; systemic
2.4
28.2
758
5904
ZX120
NOMESCO Finland
Intravenous
3.3
27.2
155
537
L01EX09
ATC
nintedanib; oral
+∞
27.2
26
*
5150X
ICD-9 Finland
Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]
+∞
27.2
26
*
R04.2
ICD-10 Finland
Haemoptysis
5.2
26.9
87
181
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.2
26.7
373
2152
R03AK07
ATC
formoterol and budesonide; inhalant
2.7
26.3
210
908
RK320
NOMESCO Finland
NA
13.8
26.2
45
34
B01AA03
ATC
warfarin; systemic
2.2
25.7
336
1871
J01FA06
ATC
roxithromycin; oral
2.1
25.6
410
2496
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
4.4
25.3
95
232
WX882
NOMESCO Finland
High dependency care
5.9
25.0
72
131
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
3.5
24.5
121
376
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
4.6
24.4
88
206
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
4.8
24.4
85
192
J47
ICD-10 Finland
Bronchiectasis
8.4
24.2
54
68
A07AA02
ATC
nystatin; oral
3.7
24.1
112
331
XF400
NOMESCO Finland
ECG with 12 standard connections
2.4
24.1
243
1187
P01BA02
ATC
hydroxychloroquine; oral
3.7
24.0
112
333
SPAT1262
SPAT
Handing over of treatment supplies
2.3
23.9
257
1297
R03BA05
ATC
fluticasone; inhalant
2.6
23.9
195
848
WX726
NOMESCO Finland
High-flow oxygen therapy
128.2
23.7
25
*
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.5
23.7
119
375
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
27.5
23.7
32
12
ZX108
NOMESCO Finland
Inhalation
20.1
23.6
35
18
WX720
NOMESCO Finland
Own respiration
4.8
23.4
80
177
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.7
23.4
107
312
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
4.4
23.2
88
217
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
5.6
22.9
68
128
I27.0
ICD-10 Finland
Primary pulmonary hypertension
46.2
22.5
27
6
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
5.4
22.4
69
136
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
5.1
22.1
72
151
H02AB07
ATC
prednisone; oral
2.6
21.8
184
815
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
32.0
21.6
28
9
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
13.2
21.3
37
29
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
12.3
21.2
38
32
J45.1
ICD-10 Finland
Nonallergic asthma
3.6
21.1
102
311
XG460
NOMESCO Finland
Short time oxymetry
6.7
20.9
54
85
A28
ICPC
Limited function/disability NOS
2.3
20.9
236
1210
WX702
NOMESCO Finland
Supraglottic ventilation device
4.5
20.6
75
177
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.4
20.4
105
337
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
33.3
20.3
26
8
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.8
20.2
88
246
R03AK08
ATC
formoterol and beclometasone; inhalant
5.4
20.2
62
122
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
19.7
292
1680
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
19.5
170
760
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.4
19.3
98
311
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
18.7
19.2
29
16
J45.0
ICD-10 Finland
Predominantly allergic asthma
3.5
19.1
93
285
J01FA10
ATC
azithromycin; systemic
1.9
19.1
446
3038
J01CA04
ATC
amoxicillin; systemic
2.0
18.9
712
5727
C01DA14
ATC
isosorbide mononitrate; oral
2.1
18.9
263
1470
Z51.5
ICD-10 Finland
Palliative care
3.0
18.8
115
415
RK110
NOMESCO Finland
NA
10.6
18.8
36
35
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.6
18.6
145
608
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
18.3
431
2931
J96.9
ICD-10 Finland
Respiratory failure, unspecified
15.7
18.0
29
19
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
6.0
17.7
49
85
J01FF01
ATC
clindamycin; systemic
2.0
17.7
279
1631
A02BC01
ATC
omeprazole; systemic
1.9
17.5
316
1944
M04AA01
ATC
allopurinol; systemic
2.2
17.1
200
1030
R05
ICD-10 Finland
Cough
2.2
17.1
205
1066
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.8
16.8
112
427
N02AA05
ATC
oxycodone; systemic
2.2
16.8
201
1046
R03BA08
ATC
ciclesonide; inhalant
3.1
16.6
96
334
XJC10
NOMESCO Finland
Oesophageal pH monitoring
23.5
16.5
23
10
C09AA05
ATC
ramipril; oral
1.9
16.3
321
2027
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
11.9
16.1
29
25
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.5
16.0
141
629
R50.9
ICD-10 Finland
Fever, unspecified
2.3
15.9
162
780
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
26.8
15.6
21
8
A02BC03
ATC
lansoprazole; oral
1.9
15.6
309
1948
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.4
15.6
77
239
R03BA01
ATC
beclometasone; inhalant
2.3
15.4
154
734
R03BA02
ATC
budesonide; inhalant
2.2
15.2
173
876
WZC30
NOMESCO Finland
Teaching
2.3
15.2
155
745
R03BB01
ATC
ipratropium bromide; inhalant
3.3
15.1
77
245
N03AX16
ATC
pregabalin; oral
2.0
15.1
239
1385
GD1UN
NOMESCO Finland
Lung circulation SPECT
14.2
15.1
25
18
WW200
NOMESCO Finland
Immunization
5.1
15.1
47
95
SPAT1263
SPAT
Sampling
1.8
15.0
417
2926
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
14.7
202
1107
XF600
NOMESCO Finland
Bloodpressure measurement
2.9
14.3
91
338
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.1
14.2
172
892
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
11.1
14.1
26
24
A02BC05
ATC
esomeprazole; systemic
1.7
13.9
378
2616
XF622
NOMESCO Finland
Measurement of minute volume of heart
17.9
13.9
21
12
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.5
13.8
49
114
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.6
13.8
102
413
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
3.0
13.8
80
280
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.4
13.7
119
526
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
13.6
290
1855
J94.1
ICD-10 Finland
Fibrothorax
76.2
13.6
15
*
48499
ICD-8 Finland
Acute interstitial pneumonia
+∞
13.6
13
*
3A006
NOMESCO Finland
NA
+∞
13.6
13
*
GD2SN
NOMESCO Finland
Lung ventilation SPECT
11.1
13.6
25
23
SPAT1255
SPAT
Intravenous administration of medicine
2.8
13.6
90
341
A01AB09
ATC
miconazole; local oral
2.6
13.5
104
431
RS123
NOMESCO Finland
NA
34.6
13.5
17
5
GDA10
NOMESCO Finland
Biopsy of lung
34.6
13.5
17
5
AN1
HP
Coronary angiography
2.0
13.5
184
1002
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
3.7
13.4
58
162
R81
ICPC
Pneumonia
4.0
13.4
53
137
GD1RA
NOMESCO Finland
Dynamic X-ray examination of respiratory organs with convetional X-ray picture
26.2
13.4
18
7
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
21.5
13.4
19
9
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.8
13.3
300
1955
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.1
13.2
159
823
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
13.1
319
2128
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.5
13.1
61
182
XF402
NOMESCO Finland
ECG with work load test
2.2
13.0
147
739
J43.2
ICD-10 Finland
Centrilobular emphysema
22.9
12.9
18
8
L04AA13
ATC
leflunomide; oral
5.1
12.9
40
81
WX402
NOMESCO Finland
General anaesthesia
2.1
12.7
146
740
D86.0
ICD-10 Finland
Sarcoidosis of lung
8.0
12.7
28
36
C02KX04
ATC
macitentan; oral
70.8
12.6
14
*
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.5
12.6
99
417
L04AA01
ATC
[U] ciclosporin; systemic
7.4
12.5
29
40
J43.8
ICD-10 Finland
Other emphysema
24.7
12.5
17
7
XX2XT
NOMESCO Finland
Other injection with other radiological guidance
13.4
12.5
21
16
XX6XT
NOMESCO Finland
Other intravascular therapy with radiological guidance
131.7
12.5
13
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.5
12.4
100
425
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.6
12.3
94
388
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.4
12.3
106
469
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
4.2
12.1
45
110
M34.1
ICD-10 Finland
CR(E)ST syndrome
27.1
12.1
16
6
GX2C5
NOMESCO Finland
Short-lasting oximetry
47.3
11.9
14
*
GX1K5
NOMESCO Finland
Diffusion capacity
47.3
11.9
14
*
JN4BD
NOMESCO Finland
Extensive body CT
2.1
11.8
141
722
R06AE07
ATC
cetirizine; oral
1.7
11.8
340
2367
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
4.8
11.7
38
81
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
16.7
11.7
18
11
R95
ICPC
Chron obstructive pulmonary disease
3.6
11.7
52
150
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.5
11.6
92
386
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
6.8
11.5
28
42
JN4AD
NOMESCO Finland
Body CT examination
2.4
11.5
100
443
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
+∞
11.5
11
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.4
11.4
54
164
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.2
11.3
119
579
F1246
NOMESCO Finland
NA
35.5
11.3
14
*
WX740
NOMESCO Finland
Nitrogen oxide therapy
35.5
11.3
14
*
5AB14
NOMESCO Finland
NA
35.5
11.3
14
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
5.6
11.3
32
59
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.7
11.3
267
1751
J45.8
ICD-10 Finland
Mixed asthma
3.8
11.2
47
129
R03DA04
ATC
theophylline; systemic, rectal
2.6
11.1
83
340
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.3
11.0
100
453
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
11.0
80
322
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.5
11.0
38
87
TKC20
NOMESCO Finland
Catheterisation of bladder
2.3
11.0
107
501
RK310
NOMESCO Finland
NA
43.8
10.9
13
*
D07AB02
ATC
hydrocortisone butyrate; topical
1.7
10.9
253
1646
R04.0
ICD-10 Finland
Epistaxis
2.3
10.9
104
482
WX002
NOMESCO Finland
Sedation and analgesia
1.8
10.9
211
1297
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.7
10.9
298
2036
RK250
NOMESCO Finland
NA
10.7
10.8
20
19
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.6
10.8
48
139
WX730
NOMESCO Finland
Conventional respirator
4.6
10.8
36
80
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
7.7
10.7
24
32
M05BA07
ATC
risedronic acid; oral
3.4
10.6
50
151
R03DC03
ATC
montelukast; oral
2.1
10.6
127
654
N02BE01
ATC
paracetamol; systemic, rectal
1.8
10.6
785
6931
J84
ICD-10 Finland
Other interstitial pulmonary diseases
+∞
10.4
10
*
F2680
NOMESCO Finland
NA
32.9
10.3
13
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.1
10.3
55
183
GX2D5
NOMESCO Finland
Sleep oximetry
19.0
10.3
15
8
R03AC03
ATC
terbutaline; inhalant
2.0
10.2
130
684
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.7
10.2
68
261
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
13.3
10.2
17
13
R06.2
ICD-10 Finland
Wheezing
3.3
10.1
50
157
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
3.8
10.1
41
110
N02AA01
ATC
morphine; systemic, rectal
4.7
10.1
33
72
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
10.1
334
2392
J05AB01
ATC
aciclovir; systemic
1.8
10.0
177
1053
S97
ICPC
Chronic ulcer skin
2.5
10.0
77
321
M34.0
ICD-10 Finland
Progressive systemic sclerosis
40.5
10.0
12
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.1
9.9
56
191
R03AC13
ATC
formoterol; inhalant
2.8
9.9
65
245
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.2
9.8
36
88
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
9.8
175
1044
E66.01
ICD-10 Finland
Obesity due to excess calories
2.7
9.8
66
255
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.1
9.7
52
174
L88
ICPC
Rheumatoid/seropositive arthritis
3.4
9.6
45
136
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
4.1
9.6
36
90
R4190
NOMESCO Finland
Nutritional therapy
3.8
9.6
40
110
SPAT1060
SPAT
Administration of oxygen
11.5
9.6
17
15
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
9.5
290
2022
FXD00
NOMESCO Finland
Use of ECHLA without concurrent surgical procedure
101.0
9.4
10
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.3
9.4
85
386
XF404
NOMESCO Finland
Ambulatory ECG
2.1
9.4
112
576
I25.2
ICD-10 Finland
Old myocardial infarction
2.1
9.3
112
577
J01FA15
ATC
telithromycin; oral
2.3
9.3
89
413
H02AB04
ATC
methylprednisolone; systemic
1.9
9.3
136
754
D07AC01
ATC
betamethasone; topical
1.6
9.2
306
2179
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.0
9.2
28
57
M10.9
ICD-10 Finland
Gout, unspecified
2.2
9.1
95
460
ZXA10
NOMESCO Finland
Bilateral
1.7
9.1
194
1219
B01AB05
ATC
enoxaparin; parenteral
1.6
9.1
301
2144
RS230
NOMESCO Finland
NA
10.2
9.0
17
17
R03AC12
ATC
salmeterol; inhalant
2.7
9.0
60
228
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
5.1
9.0
27
54
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.1
9.0
27
54
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.4
8.9
76
334
N03AX12
ATC
gabapentin; oral
1.9
8.9
142
811
A07EC01
ATC
sulfasalazine; oral, rectal
2.3
8.8
79
357
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
8.8
59
225
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
10.8
8.8
16
15
A46
ICD-10 Finland
Erysipelas
1.8
8.7
156
929
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.8
8.7
35
94
M34.8
ICD-10 Finland
Other forms of systemic sclerosis
50.4
8.7
10
*
J67.9
ICD-10 Finland
Hypersensitivity pneumonitis due to unspecified organic dust
50.4
8.7
10
*
XG467
NOMESCO Finland
Nocturnal CO2 monitoring
50.4
8.7
10
*
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.6
8.7
297
2127
J01DB01
ATC
cefalexin; oral
1.6
8.6
709
6187
J01DA01
ATC
[U] cefalexin; systemic
1.5
8.6
548
4512
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.2
8.6
93
455
R2110
NOMESCO Finland
Giving the first information
2.6
8.6
63
257
E0000UV
ATC
NA
1.5
8.6
326
2394
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.5
8.6
66
277
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.1
8.5
32
81
N19
ICD-10 Finland
Unspecified kidney failure
2.8
8.5
53
194
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
8.5
90
437
N05CF01
ATC
zopiclone; oral
1.6
8.5
309
2240
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
90.8
8.4
9
*
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
90.8
8.4
9
*
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
4.9
8.4
26
54
NH3EA
NOMESCO Finland
Feet X-ray examination with load
4.9
8.4
26
54
C08CA02
ATC
felodipine; oral
1.9
8.4
120
661
T86.8
ICD-10 Finland
Failure and rejection of other transplanted organs and tissues
+∞
8.3
8
*
J99.1*M35.0
ICD-10 Finland
Respiratory disorders in sicca syndrome [Sjögren]
+∞
8.3
8
*
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.6
8.3
36
103
R05
ICPC
Cough
1.7
8.3
190
1220
UJF32
NOMESCO Finland
Coloscopy
1.6
8.3
270
1903
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
9.5
8.3
16
17
C10AA03
ATC
pravastatin; oral
2.1
8.3
98
502
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.2
8.3
42
136
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.9
8.2
124
699
WX110
NOMESCO Finland
Local anesthesy
1.5
8.2
548
4542
C08CA05
ATC
nifedipine; systemic
2.2
8.2
84
406
J80
ICD-10 Finland
Adult respiratory distress syndrome
11.8
8.1
14
12
2AX04
NOMESCO Finland
NA
17.3
8.1
12
7
R01AD08
ATC
fluticasone; nasal
1.6
8.1
208
1379
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
8.1
78
365
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
5.1
8.1
24
48
E66.00
ICD-10 Finland
Metabolic syndrome
2.7
8.0
55
215
1CX08
NOMESCO Finland
NA
10.1
8.0
15
15
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.9
8.0
48
174
Z94.1
ICD-10 Finland
Heart transplant status
22.2
8.0
11
5
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
3.9
8.0
31
81
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
8.0
312
2297
A06AD11
ATC
lactulose; oral
1.7
7.9
171
1076
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.2
7.9
39
124
G04BE03
ATC
sildenafil; oral
4.0
7.9
30
77
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.8
7.9
32
87
J98.6
ICD-10 Finland
Disorders of diaphragm
13.2
7.9
13
10
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
7.9
365
2785
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
7.9
84
412
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
5.5
7.9
22
41
M81.9
ICD-10 Finland
Osteoporosis, unspecified
2.8
7.8
50
188
I50
ICD-10 Finland
Heart failure
2.7
7.8
53
205
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.8
7.8
138
817
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.6
7.8
226
1548
B01AF02
ATC
apixaban; oral
1.9
7.8
122
693
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.2
7.7
74
346
A02BA03
ATC
famotidine; systemic
2.6
7.7
56
225
GX1D5
NOMESCO Finland
Flow volume spirometry
45.3
7.7
9
*
6BA02
NOMESCO Finland
NA
45.3
7.7
9
*
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
7.7
111
614
J01FA09
ATC
clarithromycin; systemic
1.6
7.6
231
1598
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.1
7.6
40
134
1CX01
NOMESCO Finland
NA
25.2
7.6
10
*
R78
ICPC
Acute bronchitis/bronchiolitis
4.4
7.6
26
61
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.4
7.6
62
269
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.8
7.5
144
872
A02BA02
ATC
ranitidine; systemic
1.6
7.5
207
1396
C08CA01
ATC
amlodipine; oral
1.5
7.5
376
2912
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.5
7.5
55
224
TNH11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in ankle joint or foot joint
7.2
7.5
17
24
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
6.0
7.4
19
32
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.2
7.4
71
332
E000003
ATC
NA
2.8
7.4
44
160
A40.3
ICD-10 Finland
Sepsis due to Streptococcus pneumoniae
6.9
7.3
17
25
AK3
HP
BLTX (both lung transplants)
+∞
7.3
7
*
C02KX01
ATC
bosentan; oral
+∞
7.3
7
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
7.3
210
1429
RS221
NOMESCO Finland
NA
4.7
7.2
23
50
SPAT1254
SPAT
Administration of medicine
1.7
7.2
154
968
XG474
NOMESCO Finland
Exhalation nntrogen oxide
4.0
7.2
27
69
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
3.9
7.2
28
74
I50.1
ICD-10 Finland
Left ventricular failure
2.1
7.2
75
365
A41.9
ICD-10 Finland
Sepsis, unspecified
2.7
7.2
47
181
ZXA00
NOMESCO Finland
Right side
1.5
7.2
267
1935
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
30.2
7.2
9
*
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.8
7.1
114
654
XX4AW
NOMESCO Finland
NA
20.2
7.1
10
5
SPAT1059
SPAT
Spirometry at the office
2.4
7.1
56
238
R60.0
ICD-10 Finland
Localized oedema
1.8
7.1
112
640
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
4.8
7.0
22
47
M06.8
ICD-10 Finland
Other specified rheumatoid arthritis
10.1
7.0
13
13
T90
ICPC
Diabetes non-insulin dependent
1.5
7.0
241
1710
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.8
7.0
133
805
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.9
7.0
105
588
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
2.8
7.0
41
148
N06AA09
ATC
amitriptyline; systemic
1.9
6.9
94
509
3AC01
NOMESCO Finland
NA
5.5
6.9
19
35
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.2
6.9
70
335
M81.4
ICD-10 Finland
Drug-induced osteoporosis
13.9
6.9
11
8
WX400
NOMESCO Finland
Inhalation anesthesy
3.0
6.9
39
135
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.3
6.9
58
257
132
Kela drug reimbursment
Sarcoidosis
8.3
6.8
14
17
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
8.3
6.8
14
17
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
6.8
6.8
16
24
J46
ICD-10 Finland
Status asthmaticus
3.4
6.8
30
89
C01AA05
ATC
digoxin; systemic
1.8
6.8
114
664
E66.8
ICD-10 Finland
Other obesity
2.8
6.8
40
145
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
6.8
11
402
J92.9
ICD-10 Finland
Pleural plaque without asbestos
4.7
6.7
21
45
A01AB04
ATC
amphotericin B; local oral
2.4
6.7
54
233
RF210
NOMESCO Finland
NA
3.3
6.7
31
95
B01AC04
ATC
clopidogrel; oral
1.6
6.7
198
1355
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
6.6
150
954
RS220
NOMESCO Finland
NA
4.3
6.6
23
55
WYA20
NOMESCO Finland
Home visit
3.6
6.6
28
80
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.6
6.6
46
181
J12.8
ICD-10 Finland
Other viral pneumonia
7.9
6.6
14
18
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.8
6.6
39
141
R06.5
ICD-10 Finland
Mouth breathing
2.0
6.6
77
392
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.2
6.5
61
283
R03BB05
ATC
aclidinium bromide; inhalant
10.1
6.5
12
12
XX9XE
NOMESCO Finland
Other ultrasound examination
6.9
6.5
15
22
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.0
6.5
34
115
A07AA09
ATC
vancomycin; oral
4.3
6.4
22
52
J01GB01
ATC
tobramycin; inhalant, parenteral
70.3
6.4
7
*
FXF00
NOMESCO Finland
Decannulation after ECHLA or ECLA
70.3
6.4
7
*
XQ841
NOMESCO Finland
Examination of dermatosis with microscope
70.3
6.4
7
*
GD1FN
NOMESCO Finland
Lung ventilation isotope imaging
70.3
6.4
7
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
6.4
80
420
X59
ICD-10 Finland
Exposure to unspecified factor
1.7
6.4
148
951
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
6.4
252
1844
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
6.4
290
2184
J93.8
ICD-10 Finland
Other pneumothorax
8.2
6.3
13
16
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
6.3
71
357
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
3.7
6.3
25
68
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.7
6.3
125
766
XV5WT
NOMESCO Finland
NA
+∞
6.3
6
*
J01DA06
ATC
[U] cefuroxime; systemic
1.7
6.3
118
712
SPAT1325
SPAT
Vaccination
1.4
6.2
343
2682
RS310
NOMESCO Finland
NA
26.9
6.2
8
*
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
7.1
6.2
14
20
R03BB07
ATC
umeclidinium bromide; inhalant
7.1
6.2
14
20
UJF92
NOMESCO Finland
Capsular endoscopy
3.6
6.2
26
74
N18.8
ICD-10 Finland
Other chronic renal failure
2.6
6.2
42
166
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
5.4
6.2
17
32
R05FB02
ATC
cough suppressants and expectorants
1.4
6.2
335
2612
R29
ICPC
Respiratory symptom/complaint other
2.2
6.1
58
271
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.1
6.1
69
346
H03AA01
ATC
levothyroxine sodium; systemic
1.6
6.1
184
1263
J02AC03
ATC
voriconazole; systemic
12.6
6.1
10
8
81
HP
Angiography of the heart and coronary arteries
1.8
6.0
98
566
XQ848
NOMESCO Finland
Dermatological photography
2.9
6.0
33
115
RK290
NOMESCO Finland
NA
10.1
6.0
11
11
I20.00
ICD-10 Finland
Unstable angina
2.4
6.0
47
201
AA1AD
NOMESCO Finland
CT of head and brain
1.5
6.0
250
1844
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
215
60
44.46
307.65
2.9
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
501
731
11.89
307.65
6.5
4.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
317
373
11.60
261.95
4.2
2.8
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
215
148
17.88
247.56
2.7
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
247
218
14.38
246.87
3.1
1.5
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
533
1230
7.56
243.98
13.0
7.5
kpa
5.2
5.1
1.10
508
1179
(3027801) Oxygen [Partial pressure] in Arterial blood
532
1231
7.53
242.68
13.0
7.4
kpa
9.4
11.8
31.96
506
1180
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
249
231
13.70
241.00
3.2
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
526
1238
7.32
234.72
13.1
7.4
mmol/l
2.3
1.2
6.43
440
948
(3023419) Bacteria identified in Sputum by Culture
183
129
16.87
207.04
3.2
2.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
193
166
13.93
194.43
16.6
5.2
iu/ml
577.8
306.0
0.37
61
26
(44790048)
160
101
18.41
191.30
3.2
1.3
—
—
—
0
0
(44790047)
160
101
18.41
191.30
3.2
1.3
—
—
—
0
0
(44806118)
160
101
18.41
191.30
3.2
1.3
—
—
—
0
0
(44790049)
160
101
18.41
191.30
3.2
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
209
228
11.12
179.34
2.6
1.3
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
446
1121
6.06
178.87
14.0
7.8
%
92.9
95.3
10.09
424
1082
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
162
119
15.83
178.56
2.8
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
105
27
42.96
173.77
2.5
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
246
349
8.83
171.84
1.7
1.3
u/ml
5.1
5.3
—
6
5
(3037522) Nuclear Ab [Titer] in Serum
390
905
6.17
169.68
1.6
1.3
titre
535.5
421.3
0.66
124
203
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
140
95
16.78
160.71
3.6
1.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
546
1772
5.20
159.25
3.6
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
157
136
13.33
156.57
2.1
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
152
125
13.98
156.48
3.3
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
171
170
11.76
155.89
3.3
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
292
556
6.82
154.88
14.0
10.1
mmol/l
25.3
24.4
2.98
271
526
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
146
122
13.68
148.69
2.1
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
709
2974
5.01
145.71
14.6
5.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
431
1236
5.13
144.11
3.4
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
427
1241
5.03
139.89
3.3
1.8
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
136
128
12.01
128.02
6.9
2.7
u/ml
1171.0
2632.0
—
13
10
(3005719) IgG [Mass/volume] in Serum or Plasma
282
621
5.79
126.67
4.5
2.7
g/l
10.1
10.9
1.45
269
559
(3022096) Basophils/100 leukocytes in Blood
788
3875
4.79
123.87
15.3
5.6
%
0.5
0.6
7.56
774
3594
(3006504) Eosinophils/100 leukocytes in Blood
793
3976
4.71
119.85
15.7
5.6
%
2.4
2.9
9.06
776
3683
(3019069) Monocytes/100 leukocytes in Blood
793
3988
4.69
119.03
16.5
5.9
%
8.7
9.0
2.51
776
3711
(3002030) Lymphocytes/100 leukocytes in Blood
794
4060
4.58
114.79
16.0
5.8
%
21.9
26.0
21.21
777
3752
(3018010) Neutrophils/100 leukocytes in Blood
784
3974
4.52
114.70
15.1
5.6
%
63.8
58.5
27.06
767
3695
(3002173) Hemoglobin [Mass/volume] in Arterial blood
352
1018
4.64
113.08
16.7
8.1
g/l
122.6
120.5
0.99
338
985
(3001604) Monocytes [#/volume] in Blood
800
4194
4.47
109.58
14.6
5.3
e9/l
0.7
0.6
17.57
750
3551
(3006315) Basophils [#/volume] in Blood
800
4214
4.44
108.33
14.6
5.3
e9/l
0.0
0.0
2.51
752
3578
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
338
986
4.53
106.71
5.9
3.1
ng/l
279.1
249.9
0.47
317
908
(3023368) Bacteria identified in Blood by Culture
650
3008
3.90
105.57
7.7
4.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
801
4288
4.33
104.33
14.8
5.4
e9/l
1.9
1.8
0.21
759
3708
(3028026) IgM [Mass/volume] in Serum or Plasma
229
495
5.60
103.70
2.5
1.8
g/l
1.1
1.6
1.79
211
445
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
268
666
5.02
103.20
9.4
4.3
mmol/l
2.7
1.9
2.72
229
491
(3013115) Eosinophils [#/volume] in Blood
806
4362
4.31
102.62
16.0
5.5
e9/l
0.2
0.2
0.22
765
3767
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
245
571
5.25
101.70
20.4
10.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
319
939
4.40
98.74
15.5
6.7
mmol/l
11.9
11.4
0.44
303
894
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
167
279
6.89
98.52
2.1
1.5
titre
154.5
165.0
0.05
11
12
(3009343) pH of Capillary blood
269
695
4.82
98.43
9.8
4.3
ph
7.4
7.4
1.86
34
79
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
270
702
4.79
97.99
9.8
4.2
kpa
5.3
5.1
2.88
260
650
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
67
30
23.74
92.27
3.6
1.3
ug/l
34.2
59.4
2.67
67
30
(3000494) Fungus identified in Specimen by Culture
328
1032
4.12
92.05
3.4
1.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
106
112
10.38
91.54
3.5
4.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
258
693
4.57
89.25
12.4
6.5
mmol/l
25.4
24.4
2.81
243
651
(3047181) Lactate [Moles/volume] in Blood
167
319
6.01
85.72
12.0
7.1
mmol/l
1.4
1.4
0.03
153
279
(3001964) Herpes simplex virus Ag [Presence] in Specimen
57
21
28.60
84.17
3.3
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
110
140
8.63
82.22
3.3
2.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
94
100
10.20
80.62
2.6
1.7
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
139
235
6.64
80.59
1.3
1.2
u/ml
0.3
0.7
—
5
21
(3018572) Chloride [Moles/volume] in Blood
139
236
6.61
80.24
11.2
7.9
mmol/l
104.4
105.2
0.90
127
214
(3039000) Anion gap in Blood
139
236
6.61
80.24
11.2
7.9
mmol/l
11.5
11.2
0.48
127
214
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
107
139
8.43
78.58
1.8
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
95
107
9.64
78.07
2.6
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
83
78
11.44
77.56
1.6
1.2
u/ml
—
—
—
0
0
(3000492) Spirometry study
239
671
4.29
77.23
3.4
1.4
—
—
—
0
0
(4010399)
228
631
4.31
74.95
2.3
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
79
73
11.59
74.62
1.7
1.1
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
195
481
4.72
74.30
3.2
1.8
ug/l
2.6
2.2
0.11
173
420
(3005322) IgE [Units/volume] in Serum or Plasma
175
400
5.03
73.09
1.6
1.2
u/ml
262.8
206.6
0.44
159
361
(3012095) Magnesium [Moles/volume] in Serum or Plasma
388
1560
3.32
72.75
10.0
3.2
mmol/l
0.8
0.8
0.12
366
1455
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
186
449
4.79
72.71
9.1
5.4
%
1.8
1.6
3.74
173
423
(3006184) Hemoglobin [Mass/volume] in Capillary blood
127
217
6.50
72.68
3.2
2.2
g/l
129.5
128.8
0.07
56
168
(4306422)
83
86
10.37
72.44
1.3
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
102
138
8.06
72.30
1.4
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
804
4918
3.46
72.28
19.3
8.7
e9/l
5.4
4.3
26.57
767
4264
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
325
1179
3.51
71.85
1.4
1.2
iu/ml
46.8
36.2
0.68
120
356
(3022313) Gas panel - Capillary blood
200
519
4.50
71.33
9.9
4.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
535
2639
3.03
69.61
7.5
3.1
u/l
34.0
35.1
0.11
524
2502
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
614
3299
2.99
67.78
6.0
3.2
ng/l
2520.3
1852.3
2.06
580
2875
(3042936) Bacteria identified in Isolate by Culture
359
1432
3.25
67.46
3.7
2.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
44
15
30.53
66.43
4.2
5.9
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
46
18
26.64
66.33
3.2
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
342
1344
3.26
65.65
10.7
5.4
mmol/l
1.1
1.0
3.47
321
1233
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
91
121
8.12
65.35
1.4
1.4
u/ml
107.9
107.8
0.00
20
14
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
96
138
7.54
64.44
1.1
1.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
774
4820
3.12
63.49
14.1
6.1
umol/l
12.3
12.5
0.23
760
4559
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
147
327
5.04
63.06
1.6
2.0
u/l
39.3
37.4
0.42
132
284
(3007930) Methemoglobin/Hemoglobin.total in Blood
174
444
4.48
63.05
9.7
5.4
%
0.9
0.9
0.00
161
419
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
55
37
15.61
62.59
2.4
2.0
u/ml
2649.3
49642.2
—
13
9
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
48
25
20.04
61.79
1.1
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
75
85
9.41
61.15
1.2
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
423
1949
2.92
60.50
7.2
4.2
ng/l
456.9
308.5
0.79
381
1693
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
43
18
24.84
60.44
1.4
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
95
145
7.09
60.34
1.3
1.2
u/ml
19.0
2.7
—
10
10
(46235355) HIV 1 and 2 tests - Meaningful Use set
247
844
3.50
58.85
1.7
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
401
1820
2.91
58.66
3.3
1.7
mg/l
1.8
1.5
0.48
346
1426
(3011412) CD3 cells [#/volume] in Blood
65
64
10.74
58.66
2.1
2.1
e9/l
0.9
1.1
0.51
44
35
(3024139) IgG subclass 3 [Mass/volume] in Serum
64
62
10.91
58.40
1.2
1.2
g/l
0.4
0.5
0.26
37
44
(3028192) IgG subclass 2 [Mass/volume] in Serum
64
62
10.91
58.40
1.2
1.2
g/l
2.2
2.9
1.37
37
45
(3027135) IgG subclass 1 [Mass/volume] in Serum
64
62
10.91
58.40
1.2
1.2
g/l
9.1
7.8
0.38
35
44
(3004616) Nuclear Ab [Presence] in Serum
73
85
9.14
58.27
1.3
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
74
88
8.95
58.11
1.4
1.2
u/ml
2.7
5.0
0.29
25
24
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
716
4397
2.85
57.88
15.6
6.3
mmol/l
1.2
1.2
8.65
678
3959
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
158
400
4.45
57.63
4.9
2.7
u/ml
0.3
0.4
0.54
101
229
(3024980) IgG subclass 4 [Mass/volume] in Serum
80
106
8.07
57.53
1.4
1.6
g/l
0.7
0.9
0.62
50
81
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
111
209
5.80
57.22
2.3
1.4
g/l
0.2
0.2
0.35
104
200
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
55
44
13.12
56.71
2.8
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
102
180
6.15
56.23
1.4
1.2
u/ml
17.5
2.2
0.46
18
19
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
55
45
12.82
55.94
2.8
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
102
181
6.12
55.90
1.4
1.2
u/ml
16.1
7.0
0.47
23
26
(4062490)
63
64
10.39
55.59
1.2
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
342
1464
2.95
55.21
3.5
2.5
g/l
2.3
2.3
0.02
324
1350
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
330
1398
2.96
54.16
3.6
2.5
%
18.1
21.9
5.77
266
1186
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
65
72
9.54
53.85
2.9
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
103
192
5.82
53.60
1.4
1.2
u/ml
10.3
20.6
—
5
7
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
72
92
8.31
53.31
1.4
1.2
u/ml
3.1
6.4
0.74
44
44
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
58
57
10.69
52.35
2.7
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
48
35
14.30
52.17
1.8
1.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
54
48
11.79
52.11
2.0
2.2
e6/l
415.5
670.5
0.72
47
41
(1616796) Gas panel - Central venous blood
111
228
5.31
51.94
9.9
3.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
742
4792
2.74
51.68
17.7
7.1
mmol/l
1.2
1.2
5.55
647
4032
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
109
222
5.35
51.48
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
109
222
5.35
51.48
1.6
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
37
16
23.91
51.26
1.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
123
279
4.85
51.26
7.7
3.1
mmol/l
26.1
24.8
2.16
116
238
(3032080) INR in Blood by Coagulation assay
685
4271
2.64
50.97
17.3
11.2
inr
1.4
1.4
1.01
180
1176
(3024471) HLA-A [Type]
37
17
22.50
50.06
1.0
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
215
744
3.36
49.57
2.3
1.7
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
56
8
73.58
49.55
3.8
1.0
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
349
1593
2.76
49.07
3.6
2.5
umol/l
10.3
12.1
6.18
337
1470
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
105
217
5.25
48.73
2.4
1.5
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
51
46
11.59
48.72
2.1
2.0
%
16.6
17.8
0.15
33
22
(3036489) Thrombin time
123
291
4.64
48.62
4.7
2.2
s
21.7
22.1
0.27
115
270
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
51
47
11.34
48.03
2.1
2.3
e9/l
0.2
0.2
0.59
46
41
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
275
1122
2.94
47.62
1.3
1.3
u/ml
53.7
12.2
0.83
59
388
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
49
44
11.62
46.92
2.3
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
658
4188
2.46
44.27
10.2
4.9
g/l
32.5
34.6
16.77
628
3877
(3012544) pH of Venous blood
253
1026
2.91
43.96
5.9
3.7
—
7.4
—
0
5
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
52
56
9.70
43.90
1.7
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
102
226
4.88
43.57
14.9
4.7
mmol/l
3.8
2.8
2.52
91
155
(3030905) Polymorphonuclear cells [#/volume] in Blood
82
151
5.79
43.09
5.5
2.8
e9/l
5.3
4.6
1.49
82
151
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
46
43
11.13
42.87
4.3
4.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
231
904
2.98
42.72
2.3
2.2
g/l
0.2
0.2
0.31
217
841
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
83
156
5.68
42.67
6.1
3.2
%
61.4
59.6
0.51
83
156
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
97
211
4.95
42.33
1.8
2.1
mg/l
11.4
12.2
0.29
88
190
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
53
62
8.94
42.02
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
54
65
8.69
41.87
2.2
2.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
47
48
10.19
41.20
1.1
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
303
1394
2.63
40.90
2.2
1.5
g/l
2.7
2.7
0.16
233
783
(4268621)
54
67
8.43
40.86
2.4
2.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
33
19
17.88
40.37
1.2
1.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
90
195
4.94
39.42
7.7
2.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
71
124
6.06
39.37
1.2
1.2
u/ml
318.4
292.7
0.22
44
69
(3002179) Metamyelocytes/100 leukocytes in Blood
182
651
3.16
39.16
6.8
3.9
%
0.4
0.6
1.00
74
174
(3017181) Myelocytes/100 leukocytes in Blood
197
738
3.04
39.13
7.1
4.0
%
0.7
0.9
0.74
87
244
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
151
482
3.48
39.10
4.3
4.1
mmol/l
25.0
23.9
2.87
140
439
(40767503) Oxygen content in Capillary blood by calculation
93
209
4.77
38.99
4.8
2.5
%
15.9
15.9
0.03
47
108
(3018418) pH of Serum or Plasma
489
2850
2.31
38.62
6.9
4.0
ph
7.4
7.4
0.35
104
530
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
268
1210
2.61
37.18
4.7
3.8
u/l
287.2
248.2
2.96
262
1148
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
71
131
5.73
37.18
1.2
1.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
236
1001
2.74
37.09
5.9
3.6
kpa
6.3
5.8
4.12
218
972
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
49
61
8.37
36.94
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
46
53
9.02
36.86
2.9
1.7
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
234
998
2.72
36.32
6.1
3.6
mmol/l
2.9
2.0
2.45
193
775
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
188
717
2.96
35.99
1.7
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
233
1011
2.66
34.82
3.0
2.7
umol/l
8.8
8.9
0.05
217
893
(3000991) Gas panel - Venous blood
211
871
2.77
34.78
20.3
8.6
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
25
11
23.24
34.18
1.1
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
179
683
2.94
34.14
1.7
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
765
5545
2.29
33.44
14.7
5.1
mmol/l
7.0
6.9
1.03
738
5232
(3026782) Osmolality of Urine
367
1993
2.27
33.24
5.0
2.9
mosm/kgh2o
543.5
562.2
1.20
344
1698
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
42
51
8.53
32.27
2.3
3.0
%
37.6
34.4
0.29
33
17
(3021879) Hepatitis B virus core Ab [Presence] in Serum
128
421
3.31
31.38
1.4
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
273
1342
2.38
30.90
18.8
6.8
mmol/l
103.6
104.2
1.13
263
1302
(40758558) Short blood count panel - Blood
380
2149
2.18
30.68
13.9
6.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
75
172
4.61
30.59
1.2
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
35
36
10.01
30.45
1.2
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
415
2449
2.13
29.86
7.8
2.9
umol/l
399.8
8019.1
9.60
374
2060
(3036481) Cortisol [Moles/volume] in Serum or Plasma
181
744
2.72
29.79
2.0
2.2
nmol/l
336.8
373.2
1.19
172
671
(3018677) aPTT in Platelet poor plasma by Coagulation assay
302
1578
2.27
29.46
4.3
2.0
s
30.5
30.0
0.62
293
1528
(3019977) pH of Arterial blood
44
63
7.24
29.42
3.1
2.5
ph
7.4
7.4
0.15
27
15
(3014111) Lactate [Moles/volume] in Serum or Plasma
207
915
2.56
29.39
19.1
7.4
mmol/l
1.3
1.5
1.45
192
881
(3013707) Erythrocyte sedimentation rate by Westergren method
826
6327
2.29
29.39
12.5
4.1
mm/h
20.7
14.3
17.54
812
5767
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
457
2841
2.05
28.19
3.8
2.5
u/l
61.8
57.0
1.15
439
2617
(3000850) Epithelial cells [#/volume] in Urine
368
2115
2.12
28.02
5.1
2.6
e6/l
3.9
4.4
0.73
347
1882
(36304419) Bacteria [Presence] in Urine
424
2582
2.06
27.53
6.4
3.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
96
287
3.57
27.24
1.5
1.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
39
55
7.32
26.41
1.6
1.1
u/ml
0.6
0.9
0.13
28
31
(3008536) Aspergillus sp Ab [Presence] in Serum
29
28
10.61
26.32
1.2
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
466
2979
1.99
26.03
6.9
3.5
e6/l
53.1
101.6
0.85
405
2367
(4015189)
31
34
9.36
25.71
2.3
2.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
76
202
3.97
25.54
1.5
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
30
32
9.61
25.39
1.3
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
789
6086
2.09
25.28
9.0
4.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
256
1321
2.23
25.27
4.1
2.4
%
2.1
1.8
3.11
234
1172
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
859
6845
2.23
25.26
19.2
7.5
u/l
82.2
80.6
0.37
848
6391
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
39
58
6.94
25.18
1.3
1.1
titre
140.0
93.3
—
8
9
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
26
23
11.56
24.97
1.2
1.1
ratio
1.0
1.1
—
8
7
(3033658) Prothrombin time (PT) actual/Normal
382
2315
2.00
24.52
8.9
4.1
%
80.9
84.1
1.33
377
2260
(3025159) Blasts/100 leukocytes in Blood
154
643
2.63
24.32
7.4
4.1
%
0.0
0.6
0.62
79
188
(3031040) Bacteria [#/volume] in Urine by Automated count
775
5993
2.03
23.90
8.4
4.9
e6/l
142.8
1882.9
1.71
13
121
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
21
14
15.28
23.69
1.0
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
91
288
3.36
23.60
6.1
3.5
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
24
21
11.66
23.18
5.2
7.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
158
686
2.53
22.96
7.7
4.1
%
0.1
0.1
0.87
85
221
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
48
97
5.13
22.71
2.0
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
48
97
5.13
22.71
2.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
48
97
5.13
22.71
2.0
1.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
496
3363
1.88
22.18
8.1
4.0
e6/l
80.7
117.2
0.37
413
2512
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
21
16
13.36
22.01
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
20
14
14.54
21.96
1.1
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
20
14
14.54
21.96
1.1
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
20
14
14.54
21.96
1.1
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
20
14
14.54
21.96
1.1
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
145
621
2.54
21.64
2.0
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
512
3528
1.86
21.56
6.8
3.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
36
59
6.28
21.21
2.2
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
36
59
6.28
21.21
2.2
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
36
59
6.28
21.21
2.2
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
36
59
6.28
21.21
2.2
1.7
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
48
103
4.83
21.19
1.0
1.1
g/l
1.6
1.6
0.23
41
93
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
20
15
13.57
21.13
1.1
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
416
2704
1.87
20.92
6.6
3.4
e6/l
0.4
0.5
0.40
357
2106
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
32
47
6.99
20.88
2.2
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
32
47
6.99
20.88
2.2
1.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
497
3418
1.84
20.84
3.4
2.2
nmol/l
74.5
78.6
2.89
464
2957
(3007853) Bacteria identified in Skin by Aerobe culture
213
1096
2.17
20.80
2.7
1.8
—
—
—
0
0
(3020891) Body temperature
112
430
2.79
20.75
7.3
4.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
32
48
6.84
20.49
2.2
1.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
157
719
2.38
20.20
2.1
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
437
2909
1.84
20.19
5.0
2.1
u/l
124.9
242.4
3.40
416
2724
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
400
2595
1.86
20.04
3.1
2.2
mg/l
3.7
3.1
2.78
365
2195
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
127
529
2.59
20.02
2.2
1.9
g/l
1.6
1.6
0.47
113
459
(3039162) Centromere protein B Ab [Units/volume] in Serum
42
86
5.04
19.57
1.4
1.2
u/ml
71.7
78.7
—
7
5
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
542
3882
1.79
19.40
7.2
4.2
ng/l
48.9
63.0
0.66
454
3008
(3023520) Reticulocytes [#/volume] in Blood
193
984
2.17
19.17
3.2
2.5
e9/l
75.2
68.3
1.57
142
775
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
24
28
8.74
18.95
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
71
221
3.37
18.88
2.2
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
53
135
4.08
18.86
1.5
1.1
u/ml
77.6
30.6
—
12
8
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
111
446
2.66
18.79
3.1
1.9
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
181
916
2.17
18.26
2.2
2.7
g/l
65.0
65.9
0.72
171
819
(3051651) Icteric interference index of Serum or Plasma
33
58
5.84
18.13
6.9
3.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
19
17
11.36
18.02
1.2
1.9
%
85.7
90.2
0.13
14
11
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
19
17
11.36
18.02
1.2
1.1
%
89.1
89.9
0.04
14
11
(3026008) Bacteria identified in Urine by Culture
434
2978
1.76
17.45
4.2
3.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
278
1666
1.90
17.44
11.0
4.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
86
319
2.84
16.95
1.5
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
491
3510
1.73
16.93
4.1
2.8
ug/l
204.4
155.5
2.54
466
3171
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
150
727
2.23
16.78
1.9
1.7
%
1.6
1.6
0.01
129
596
(3004588) Protein electrophoresis panel - Serum or Plasma
156
769
2.20
16.74
2.0
2.5
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
19
19
10.16
16.74
5.1
7.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
69
229
3.15
16.54
2.8
3.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
121
544
2.38
16.11
3.7
3.0
e9/l
5.1
4.2
2.69
103
389
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
264
1599
1.86
15.84
5.4
3.2
e6/l
2.2
1.8
0.36
175
928
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
29
52
5.70
15.61
1.0
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
98
407
2.55
15.48
2.6
1.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
69
239
3.02
15.38
1.6
1.6
iu/ml
36.7
24.5
0.11
17
55
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
28
52
5.50
14.53
2.2
2.3
e6/l
562.3
610.0
0.13
16
22
(3023183) Ammonium ion [Moles/volume] in Plasma
65
227
2.98
14.29
3.1
2.3
umol/l
31.7
33.8
0.37
58
181
(3004809) Band form neutrophils/100 leukocytes in Blood
54
175
3.20
13.48
5.3
4.1
%
1.6
1.4
0.19
44
137
(3021589) Normoblasts [#/volume] in Blood
499
3733
1.62
13.45
24.9
9.9
e9/l
0.0
0.0
0.23
426
3030
(3051611) Lipemic interference index of Serum or Plasma
36
94
3.93
12.43
7.0
3.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
67
258
2.70
12.32
1.4
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
17
22
7.83
12.31
1.9
2.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
14
10.12
12.25
1.0
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
15
17
8.93
12.02
2.3
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
151
831
1.95
11.89
4.4
3.0
kpa
4.3
4.5
0.44
140
806
(3047007) Chlamydophila sp Ab [Presence] in Serum
31
75
4.23
11.84
1.1
1.3
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
26
55
4.82
11.70
3.2
1.7
mmol/l
8.9
9.6
0.37
21
45
(3004451) EKG impression Narrative
27
59
4.67
11.69
1.5
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
63
242
2.70
11.64
2.6
3.0
mg/l
2.0
1.8
1.23
58
217
(3004119) Hemoglobin [Mass/volume] in Venous blood
128
670
2.03
11.61
6.7
3.2
g/l
121.5
125.9
1.23
116
653
(21494814) CD8 cells/100 lymphocytes in Specimen
16
21
7.72
11.44
2.0
1.5
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
37
105
3.61
11.37
2.0
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
13
13
10.11
11.35
5.4
9.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
26
57
4.65
11.22
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
26
57
4.65
11.22
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
26
57
4.65
11.22
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
26
58
4.57
10.99
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
26
58
4.57
10.99
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
26
58
4.57
10.99
1.3
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
44
146
3.10
10.60
1.2
1.3
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
425
3189
1.55
10.54
6.3
3.4
mmol/l
2.3
2.3
1.67
374
2730
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
615
5001
1.53
10.49
6.1
3.1
u/l
77.1
55.7
4.65
586
4563
(3019309) Folate [Moles/volume] in Red Blood Cells
308
2161
1.59
10.18
2.0
1.8
nmol/l
1130.8
1183.5
0.39
249
1624
(3007566) Smooth muscle Ab [Titer] in Serum
53
201
2.72
10.06
1.3
1.2
titre
182.9
82.9
—
7
17
(3008757) Leukocyte morphology finding [Identifier] in Blood
39
128
3.12
9.59
7.1
4.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
45
161
2.87
9.53
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
171
1050
1.75
9.39
6.3
3.6
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
15
23
6.60
9.37
1.3
2.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
132
755
1.85
9.18
5.3
3.9
ng/l
119.9
96.8
1.49
119
650
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
78
370
2.19
9.14
2.5
3.6
ratio
1.7
1.7
—
6
35
(3022217) INR in Platelet poor plasma by Coagulation assay
225
1497
1.63
9.13
33.8
30.3
inr
1.6
1.5
0.27
23
201
(3034860) Kappa light chains.free [Mass/volume] in Serum
79
379
2.17
9.00
2.5
3.6
mg/l
70.4
75.0
0.09
59
318
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
12
9.25
8.99
1.6
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
12
15
8.08
8.87
1.5
2.3
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
13
18
7.30
8.86
1.3
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
78
380
2.13
8.56
2.5
3.6
mg/l
63.9
78.3
0.17
57
321
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
29
86
3.44
8.39
1.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
497
3984
1.46
8.35
3.4
2.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
80
398
2.09
8.32
2.1
2.7
g/l
3.4
3.2
1.22
62
310
(3019832) Treponema pallidum Ab [Presence] in Serum
61
274
2.30
8.16
1.5
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
137
821
1.77
8.15
3.0
2.4
u/l
37.7
34.0
0.62
125
684
(40760888) Immunoglobulin light chains.free panel - Serum
61
275
2.29
8.09
2.6
3.8
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
46
182
2.60
8.08
1.4
1.5
g/l
31.5
31.1
0.08
36
164
(3009508) Creatinine [Moles/volume] in Urine
391
3014
1.47
7.95
3.7
3.2
mmol/l
7.1
7.4
0.71
328
2464
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
516
4191
1.44
7.95
6.8
4.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
61
281
2.24
7.70
3.4
3.3
nmol/l
0.8
0.8
0.12
49
218
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
48
199
2.48
7.67
1.4
1.5
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
17
36
4.78
7.65
1.2
1.3
%
33.7
26.8
0.27
11
25
(3027273) Bicarbonate [Moles/volume] in Venous blood
99
548
1.89
7.62
8.0
3.1
mmol/l
26.4
25.1
1.74
87
529
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
12
18
6.73
7.62
1.2
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
42
164
2.62
7.59
1.5
1.4
e6/l
9729.2
1507.5
0.52
32
118
(1761868) Lipid panel - Serum or Plasma
159
2376
0.61
7.48
2.8
3.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
426
1.97
7.26
2.1
2.6
g/l
3.7
3.8
0.03
61
306
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
63
1215
0.49
7.24
8.4
8.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
382
2973
1.44
7.23
3.9
3.3
mg/l
968.2
274.7
1.42
292
1947
(3012441) Differential panel - Pleural fluid
37
139
2.72
7.21
1.5
1.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
427
1.97
7.21
2.1
2.6
g/l
7.9
7.5
1.13
63
313
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
81
427
1.97
7.21
2.1
2.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
10
13
7.75
7.13
2.0
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
31
108
2.93
6.94
2.8
2.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
177
1183
1.59
6.93
1.3
1.3
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
152
979
1.64
6.92
2.7
2.5
ug/l
13.8
6.4
3.58
137
852
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
236
1690
1.51
6.77
5.1
3.0
e6/l
0.9
1.1
0.61
149
1011
(3045788) Cell count panel - Pleural fluid
34
130
2.67
6.43
1.4
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
395
3144
1.40
6.41
4.4
4.0
mg/mmol
19.3
9.0
2.02
287
2027
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
75
402
1.93
6.38
2.2
2.7
g/l
10.7
10.4
0.12
63
336
(3044242) Glucose [Moles/volume] in Arterial blood
22
66
3.38
6.30
1.9
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
22
68
3.28
6.02
1.8
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
22
68
3.28
6.02
1.8
1.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
23
5.26
6.01
1.3
1.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
37
153
2.47
6.00
2.8
2.8
—
—
—
0
0
(44806071)
9
6
15.10
5.91
1.0
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
68
363
1.93
5.87
1.9
2.8
g/l
0.8
1.5
0.60
63
310
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
25
85
2.99
5.87
1.2
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
10
9
11.20
5.80
1.0
1.2
%
98.1
59.2
—
10
9
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
9
11.20
5.80
1.0
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
19
55
3.50
5.75
1.8
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
19
55
3.50
5.75
1.8
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
91
538
1.75
5.69
1.2
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
14
33
4.28
5.57
1.1
1.1
u/ml
1.2
4.2
—
6
12
(3000093) Morphology [Interpretation] in Blood Narrative
27
99
2.77
5.56
1.3
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
40
178
2.30
5.54
1.2
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
17
47
3.66
5.49
1.8
2.1
u/ml
2477.1
1700.3
0.22
17
47
(3041096) Erythrocytes [Presence] in Urine by Automated
289
2230
1.40
5.47
5.6
3.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
9
8
11.33
5.29
1.8
2.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
8
6
13.42
5.08
1.1
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
30
122
2.50
5.07
1.1
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
18
55
3.31
5.04
1.1
1.1
u/ml
1.7
4.1
—
8
26
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
9
9
10.07
5.03
1.2
1.6
%
119.9
87.7
—
9
9
(3002385) Erythrocyte distribution width [Ratio]
739
6643
1.35
5.02
58.8
21.2
%
15.0
13.9
47.15
728
6491
(3017704) Immunofixation for Urine
21
71
3.00
5.00
1.3
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
73
422
1.78
4.95
1.2
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
33
144
2.33
4.81
1.5
1.3
e6/l
226213.8
101180.4
0.47
23
90
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
19
62
3.10
4.80
1.1
1.2
u/ml
1.0
1.1
—
9
25
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
39
184
2.16
4.74
1.2
1.2
u/l
29.4
43.1
0.51
34
156
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
84
517
1.68
4.58
2.5
2.5
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
51
270
1.93
4.57
1.4
1.5
ug/g
257.8
274.4
0.21
31
164
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
11
8.24
4.56
1.1
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
692
6203
1.32
4.53
7.8
4.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
498
4275
1.31
4.45
5.5
4.0
estimate
0.0
0.0
0.50
123
776
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
29
124
2.38
4.44
1.4
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
745
8078
0.75
4.41
5.2
4.8
mmol/l
4.2
4.4
4.45
673
7307
(3035880) pH of Pleural fluid
20
71
2.85
4.40
1.3
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
736
7991
0.75
4.37
5.1
4.7
mmol/l
1.3
1.4
4.54
657
7152
(3021788) Differential panel - Synovial fluid
39
191
2.08
4.34
1.3
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
10
22
4.58
4.31
1.7
3.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
29
126
2.34
4.29
1.4
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
29
126
2.34
4.29
1.4
1.5
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
7
6
11.73
4.28
2.6
2.0
%
0.9
1.9
—
7
6
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
114
2.40
4.26
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
17
56
3.07
4.25
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
309
2495
1.33
4.25
1.9
1.6
nmol/l
17.9
20.3
2.16
286
2100
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
29
127
2.32
4.22
1.4
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
29
127
2.32
4.22
1.4
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
770
8296
0.75
4.22
5.5
5.4
mmol/l
2.4
2.6
8.83
685
7457
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
115
2.38
4.18
6.0
3.6
%
53.3
55.4
0.17
21
76
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
11
27
4.11
4.17
6.5
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
29
128
2.30
4.15
1.4
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
488
4205
1.29
4.14
7.5
5.3
estimate
0.0
0.0
0.00
124
799
(3009542) Hematocrit [Volume Fraction] of Blood
783
7180
1.33
4.14
52.0
19.2
%
37.5
38.7
2.33
481
4459
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
192
2490
0.72
4.05
2.4
3.3
ug/l
0.7
0.8
0.60
124
1778
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
890
8334
1.38
3.99
53.1
17.5
mg/l
25.8
28.0
1.70
862
6836
(3011648) Oxygen content in Venous blood
21
81
2.62
3.99
2.0
3.3
%
10.2
10.9
0.27
21
81
(40761535) Cells panel - Urine sediment
49
848
0.56
3.96
5.9
3.4
—
—
—
0
0
(4035726)
115
792
1.51
3.93
1.5
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
30
138
2.21
3.92
1.0
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
489
4239
1.28
3.88
5.5
3.9
estimate
0.0
0.0
0.00
123
806
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
54
2.99
3.86
1.1
1.1
u/ml
1.0
1.0
—
5
22
(3042111) Morphology [Interpretation] in Bone marrow Narrative
38
194
1.99
3.81
1.8
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
49
276
1.81
3.68
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
109
758
1.49
3.57
6.3
3.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
62
379
1.67
3.52
2.0
3.3
pmol/l
4.1
4.3
1.13
51
328
(3045142) Bone marrow Pathology biopsy report
25
112
2.26
3.50
1.2
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
86
571
1.55
3.49
5.2
2.8
e6/l
0.2
0.3
0.67
86
558
(3017817) Protein [Mass] in Urine collected for unspecified duration
24
106
2.29
3.47
1.7
2.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
36
188
1.95
3.42
1.3
1.3
mmol/l
69.0
62.3
0.43
31
154
(3037121) Protein [Mass/volume] in Urine
61
375
1.66
3.40
3.1
2.9
g/l
0.4
0.3
0.48
29
138
(3044941) Cell count panel - Synovial fluid
31
154
2.04
3.38
1.4
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
8
14
5.75
3.34
16.0
10.1
mmol/l
6.0
6.1
—
8
14
(3018851) Theophylline [Moles/volume] in Serum or Plasma
8
14
5.75
3.34
2.8
1.4
umol/l
47.5
38.6
—
8
14
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
25
115
2.20
3.30
1.4
1.5
%
61.2
63.1
0.09
17
78
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
25
115
2.20
3.30
1.0
1.1
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
469
4108
1.25
3.23
2.4
2.1
pmol/l
92.4
92.3
0.01
258
2177
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
766
8178
0.78
3.22
5.8
5.1
mmol/l
6.0
6.1
1.12
689
7273
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
142
1063
1.39
3.14
3.6
4.0
ug/l
17.8
25.7
0.24
125
892
(3000475) Leukocytes [#/volume] in Synovial fluid
42
239
1.79
3.09
1.5
1.7
e6/l
11114.7
17417.4
0.77
32
170
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
297
3514
0.79
3.08
3.5
4.8
%
22.6
21.7
0.33
95
1855
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
5
10.04
2.98
2.4
3.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
193
1531
1.32
2.92
1.3
1.2
u/ml
1.0
1.5
0.74
40
377
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
722
7727
0.80
2.86
4.8
4.2
mmol/l
1.4
1.3
7.41
650
6860
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
14
53
2.66
2.80
2.5
1.6
—
—
—
0
0
(3014891) Appearance of Pleural fluid
9
23
3.94
2.77
2.6
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
6
8.36
2.75
1.8
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
734
7830
0.81
2.75
41.9
16.5
ml/min/173m2
68.3
73.1
6.27
658
6498
(40768806) Pleura Pathology biopsy report
28
146
1.94
2.72
1.6
1.5
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
28
150
1.89
2.53
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
94
683
1.41
2.50
3.0
2.2
nmol/l
12.0
12.0
0.02
81
583
(3000330) Specific gravity of Urine by Test strip
30
515
0.57
2.44
4.5
4.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
47
297
1.61
2.43
1.5
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
260
2192
1.24
2.41
1.9
1.8
pmol/l
42222716.1
16723211.2
0.26
225
1782
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
5
8
6.27
2.37
1.0
1.0
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
8
22
3.66
2.36
1.3
1.6
ug/l
21.3
425.1
—
8
17
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
12
46
2.63
2.36
1.0
1.2
u/l
110.5
104.1
0.09
12
39
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
248
0.40
2.34
1.8
1.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
9
28
3.23
2.31
1.1
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
14
299
0.46
2.27
4.1
5.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
265
2256
1.23
2.23
3.8
2.5
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
36
2.79
2.20
2.2
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
36
2.79
2.20
1.8
1.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
322
0.49
2.20
1.6
1.4
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
24
3.35
2.18
1.6
1.3
ug/l
8.4
9.8
—
8
24
(40768443) Skin Pathology biopsy report
57
387
1.50
2.18
1.4
1.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
23
122
1.90
2.17
1.1
1.0
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
166
0.36
2.15
1.0
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
61
2.31
2.15
1.8
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
61
2.31
2.15
1.8
1.2
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
11
43
2.57
2.10
1.0
1.2
u/l
90.5
24.1
0.87
11
36
(3035320) C reactive protein [Mass/volume] in Body fluid
13
56
2.34
2.05
2.8
2.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
15
4.02
2.04
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
272
0.47
2.02
1.4
1.7
—
—
—
0
0
(4034850)
14
284
0.49
1.99
9.7
13.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
374
0.55
1.99
2.0
1.8
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
16
77
2.09
1.97
3.0
2.9
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
11
4.56
1.94
1.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
40
2.51
1.84
4.6
2.8
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
40
2.51
1.84
1.1
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
40
2.51
1.84
4.6
2.8
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
40
2.51
1.84
1.1
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
16
301
0.52
1.83
1.4
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
334
2969
1.18
1.74
4.3
2.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
13
3.86
1.71
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
647
6071
1.16
1.67
4.2
3.7
pmol/l
15.0
15.1
0.57
593
5363
(3019225) pH of Specimen
121
979
1.27
1.62
6.6
4.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
13
63
2.08
1.60
1.5
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
13
63
2.08
1.60
1.5
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
51
365
1.42
1.56
1.1
1.2
iu/ml
67.1
159.8
2.44
14
139
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
57
2.12
1.55
1.3
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
33
2.43
1.54
1.1
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
22
130
1.71
1.54
2.0
1.4
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
44
2.28
1.53
1.1
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
11
51
2.17
1.51
1.5
1.4
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
21
2.87
1.50
1.0
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
28
2.51
1.45
1.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
32
213
1.52
1.42
1.9
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
19
111
1.72
1.39
3.2
2.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
74
1.90
1.39
1.1
1.0
—
—
—
0
0
(4024509)
16
89
1.81
1.37
1.6
1.6
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
24
2.51
1.30
1.8
2.2
mmol/l
1.2
1.2
—
6
24
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
18
106
1.71
1.30
1.2
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
19
114
1.68
1.28
1.1
1.2
—
—
—
0
0
(3013512) EKG study
322
2919
1.15
1.26
7.1
4.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
402
4350
0.88
1.26
4.1
5.5
ug/l
2.2
3.4
1.54
344
3847
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
25
2.41
1.24
13.7
2.9
%
14.8
13.2
—
6
25
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
65
506
1.30
1.22
4.6
2.7
%
0.6
0.7
0.70
65
492
(3000012) Reticulocyte production index
10
49
2.05
1.22
1.8
1.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
37
2.17
1.21
1.8
1.8
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
22
140
1.58
1.21
2.5
2.4
mg/l
25.6
20.4
—
8
33
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
26
2.31
1.19
12.5
17.3
nmol/l
1680.5
1659.7
—
6
26
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
26
2.31
1.19
1.0
1.2
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
26
2.31
1.19
1.8
2.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
10
50
2.01
1.16
1.5
1.7
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
15
87
1.73
1.15
1.9
2.2
u/field
1.6
2.2
—
10
28
(40768793) Breast Pathology biopsy report
8
155
0.51
1.14
1.8
1.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
30
2.34
1.12
1.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
40
2.01
1.12
1.4
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
93
768
1.23
1.10
1.7
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
46
347
1.34
1.09
8.9
3.3
mmol/l
4.0
4.0
0.43
39
317
(3035933) Granulocytes/100 leukocytes in Blood
5
21
2.39
1.09
2.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
303
0.65
1.09
1.1
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
41
1.96
1.09
1.0
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
18
113
1.60
1.06
1.9
2.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
12
67
1.80
1.05
1.3
1.4
—
55.0
—
0
8
(3048689) Calprotectin [Mass/mass] in Stool
94
786
1.21
1.00
1.9
2.1
ug/g
226.8
168.4
0.63
79
609
(40768804) Tissue Pathology biopsy report
364
3382
1.11
0.94
2.6
2.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
37
1.90
0.94
1.0
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
6
28
2.15
0.91
1.2
1.0
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
14
86
1.64
0.91
1.4
1.3
%
41.2
30.3
—
8
54
(3033799) Differential panel - Peritoneal fluid
6
29
2.07
0.89
1.7
2.2
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
29
2.07
0.89
1.0
1.2
iu/ml
572.8
160.6
—
6
29
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
87
1.62
0.87
1.1
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
15
95
1.59
0.87
2.3
1.2
nmol/l
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
223
2023
1.13
0.87
4.5
3.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
17
113
1.51
0.82
2.1
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
32
1.88
0.82
1.0
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
21
292
0.71
0.78
1.1
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
347
3255
1.10
0.73
5.8
4.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
14
207
0.67
0.73
4.6
2.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
9
57
1.58
0.71
10.2
4.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
41
1.71
0.70
2.6
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
41
1.71
0.70
1.0
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
58
1.56
0.70
2.0
2.6
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
21
152
1.39
0.69
1.9
1.6
iu/l
3.4
4.9
—
8
41
(3006462) Nitrate [Presence] in Urine
7
43
1.63
0.67
4.1
3.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
14
95
1.48
0.64
2.6
1.2
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
5
29
1.73
0.64
5.0
3.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
227
2101
1.10
0.63
1.5
1.3
—
—
—
0
0
(4094501)
15
211
0.71
0.62
1.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
208
1919
1.10
0.62
5.6
4.4
kg/l
1.0
1.0
0.79
48
286
(3013139) Helicobacter pylori Ag [Presence] in Stool
39
478
0.81
0.62
1.1
1.3
—
—
—
0
0
(3036603) Volume of Urine
8
49
1.64
0.62
1.4
1.5
—
1806.5
—
0
11
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
6
104
0.57
0.62
1.2
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
30
1.67
0.61
2.8
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
105
932
1.14
0.61
1.2
1.3
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
13
88
1.48
0.60
1.6
1.3
e6/l
9446.0
129087.7
—
8
60
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
11
162
0.68
0.58
1.4
1.8
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
6
36
1.67
0.56
1.2
1.2
—
64.4
—
0
5
(3035637) Corticotropin [Mass/volume] in Plasma
14
98
1.43
0.56
1.6
1.7
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
18
240
0.75
0.56
6.9
3.5
mmol/l
7.0
7.7
1.07
18
234
(3014765) Yersinia sp identified in Stool by Organism specific culture
29
230
1.27
0.55
1.2
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
870
8543
1.09
0.55
42.9
16.8
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
55
642
0.85
0.54
1.5
1.4
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
6
38
1.58
0.54
2.8
2.0
e6/l
285.3
968.9
—
6
32
(40768441) Liver Pathology biopsy report
9
60
1.50
0.54
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
29
232
1.26
0.52
1.2
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
768
7511
1.08
0.52
5.5
4.6
mu/l
2.1
2.0
0.36
711
6690
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
6
40
1.50
0.51
8.3
5.6
—
53.3
—
0
7
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
9
64
1.41
0.51
1.1
3.7
u/ml
16.2
50.8
—
9
64
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
34
280
1.22
0.49
2.7
3.3
u/ml
44.3
69.2
0.59
34
267
(3019550) Sodium [Moles/volume] in Serum or Plasma
896
8824
1.09
0.48
58.0
21.0
mmol/l
138.9
139.6
12.41
881
8584
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
27
218
1.24
0.47
1.3
1.3
—
—
—
0
0
(4211845)
7
49
1.43
0.46
4.1
3.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
7
50
1.40
0.45
3.6
1.5
—
76.4
—
0
5
(3006653) Thiamine [Moles/volume] in Blood
7
51
1.37
0.44
1.0
1.1
nmol/l
119.6
135.7
—
7
51
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
113
1.33
0.42
1.7
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
57
1.41
0.42
2.0
1.9
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
179
1908
0.93
0.41
3.2
3.1
mmol/l
2.5
2.5
3.94
142
1669
(3008898) HLA-B27 [Presence]
21
168
1.25
0.40
1.0
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
896
8844
1.08
0.39
58.6
21.1
mmol/l
4.0
4.0
3.58
881
8594
(3010813) Leukocytes [#/volume] in Blood
896
9071
0.93
0.39
65.2
25.5
e9/l
8.6
6.9
32.45
875
8765
(3000963) Hemoglobin [Mass/volume] in Blood
896
9070
0.93
0.38
65.6
25.7
g/l
129.3
133.4
10.95
884
8892
(3026361) Erythrocytes [#/volume] in Blood
896
9069
0.93
0.38
65.1
25.5
e12/l
4.3
4.4
4.14
875
8763
(3035941) MCH [Entitic mass]
896
9068
0.93
0.37
64.8
25.4
pg
30.3
30.5
1.97
885
8891
(3024731) MCV [Entitic volume]
896
9068
0.93
0.37
64.9
25.4
fl
92.5
91.7
3.86
885
8893
(3007461) Platelets [#/volume] in Blood
896
9067
0.93
0.37
65.2
25.5
e9/l
244.0
237.3
2.06
879
8795
(3002256) Pathology report gross observation
107
1159
0.91
0.36
1.4
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
93
853
1.10
0.35
1.4
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
79
0.63
0.35
1.0
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
23
191
1.21
0.33
1.4
1.8
nmol/l
43.4
43.3
0.01
23
178
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
6
46
1.31
0.33
1.0
1.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
10
74
1.35
0.32
1.1
1.1
mmol/l
36.4
33.5
—
10
69
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
6
47
1.28
0.32
1.5
1.4
g/l
1.0
0.9
—
6
47
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
154
0.78
0.32
5.7
2.8
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
13
101
1.29
0.31
1.0
1.1
iu/ml
1.6
45.2
—
5
17
(4146454)
15
122
1.23
0.27
2.7
2.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
12
95
1.27
0.26
1.1
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
246
2374
1.05
0.24
6.5
4.2
estimate
0.0
0.0
0.50
115
754
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
81
0.74
0.24
1.0
1.3
—
—
—
0
0
(1002224) Polysomnography panel
19
222
0.85
0.23
1.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
19
162
1.18
0.23
1.1
1.3
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
5
42
1.19
0.21
1.2
1.4
%
1.2
1.7
—
5
34
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
17.3
—
0
12
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
782
7902
0.96
0.21
8.0
6.6
mmol/mol
44.0
41.1
3.83
730
7178
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
36
325
1.11
0.21
1.7
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
230
1.13
0.20
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
10
80
1.25
0.20
1.4
1.2
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
48
1.25
0.20
1.0
1.7
nmol/l
13.5
16.0
—
6
42
(3022621) pH of Urine by Test strip
66
617
1.07
0.19
5.5
3.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
52
1.15
0.19
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
58
1.21
0.18
1.9
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
121
0.82
0.18
2.1
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
70
1.14
0.16
1.5
1.2
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
23
254
0.90
0.14
5.7
3.4
mmol/l
1.5
1.6
0.32
23
248
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
28
257
1.09
0.13
1.4
1.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
181
1.11
0.12
1.4
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
884
8794
1.03
0.12
25.8
11.1
u/l
24.3
25.1
0.93
872
8418
(3004716) Salmonella sp identified in Stool by Organism specific culture
32
298
1.08
0.11
1.3
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
41
433
0.94
0.10
1.4
1.4
—
57.1
—
0
23
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
47
490
0.96
0.08
2.3
2.6
—
12.1
—
0
12
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
72
0.83
0.07
1.3
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
21
225
0.93
0.07
11.2
4.0
mg/l
34.3
31.2
0.10
13
148
(4281824)
8
75
1.07
0.07
1.4
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
81
0.86
0.07
1.1
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
82
0.85
0.07
1.6
2.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
69
711
0.97
0.07
3.9
3.2
ml/min/173m2
42.6
59.3
3.17
28
310
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
115
1169
0.98
0.05
4.6
4.8
%
32.6
32.7
0.02
86
750
(3003338) MCHC [Mass/volume]
661
6589
1.01
0.03
60.9
23.4
g/l
327.2
331.7
24.32
652
6535
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
226
2246
1.01
0.02
1.8
1.6
mmol/l
1.5
1.3
3.38
204
1838
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
28
273
1.03
0.01
2.0
2.6
ug/min
178.0
76.9
0.51
20
168
(3020961) Endomysium IgA Ab [Titer] in Serum
29
289
1.00
0.00
1.0
1.1
titre
—
27.3
—
0
7
(3049717) Cytology report of Urine Cyto stain
50
505
0.99
0.00
2.7
2.9
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
6
68
0.88
0.00
1.3
2.1
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
37
370
1.00
0.00
2.9
2.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
59
0.85
0.00
8.0
17.0
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
22.3
—
0
6
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
9
91
0.99
0.00
1.6
1.2
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
9
91
0.99
0.00
1.6
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
9
94
0.96
0.00
1.0
1.2
nmol/l
296.3
348.4
—
9
75
(3027944) Amphetamines [Presence] in Urine
9
89
1.01
0.00
1.6
1.2
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
15.6
—
215.3
—
0
7
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
71
0.99
0.00
2.0
1.2
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
87
0.92
0.00
1.5
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
9
89
1.01
0.00
1.6
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint ILD_INSUFFICIENCY and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ILD_INSUFFICIENCY | 8.21 [6.16, 10.94] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.326 |
During the follow-up period (1.1.1998 — 31.12.2019), 1133 out of 1651 females with ILD_INSUFFICIENCY died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ILD_INSUFFICIENCY | 7.529 [5.54, 10.23] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.007 |
During the follow-up period (1.1.1998 — 31.12.2019), 1687 out of 2465 males with ILD_INSUFFICIENCY died.
Mortality risk
Mortality risk for people of age
years, who have ILD_INSUFFICIENCY.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.882% | 1.479% |
| 5 | 5.567% | 7.869% |
| 10 | 12.156% | 19.449% |
| 15 | 22.803% | 33.892% |
| 20 | 37.258% | 52.12% |
Relationships between endpoints
↥Index endpoint: ILD_INSUFFICIENCY – ILD-related respiratory insufficiency
GWS hits: 6
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data